Latest News by Industry
DUBLIN--(BUSINESS WIRE)--Nov 10, 2022--
The "Proton Therapy Market By Indication, By Product Type, By End User: Global Opportunity Analysis and Industry Forecast, 2021-2031" report has been added to ResearchAndMarkets.com's offering.
The global proton therapy market was valued at $438.33 million in 2021, and is projected to reach $1579.39 million by 2031, registering a CAGR of 13.65% from 2022 to 2031.
Proton therapy is the most precise and advanced type of radiation therapy. It is widely used to treat cancer. It has a number of advantages over traditional radiation therapy, in terms of efficacy and adverse effects. It is a pleasant, non-invasive treatment that helps patients retain their quality of life and return to normal activities fast.
It enables doctors to administer full or greater treatment dosages that kill primary tumors without harming healthy tissues or organs. Major limitations of photon therapy or other particle therapies are overcome by proton therapy. Advancements in technology have increased adoption of proton therapy for treatments of various cancers across the globe.
Demand for proton therapy is anticipated to increase globally during the forecast period, owing to increase in prevalence of cancer and surge in number of awareness campaigns about benefits of proton therapy and technological advancements in radiotherapy devices. Moreover, patients are eager to know more about proton therapy treatment process and increase in recognition of proton therapy drive growth of the market, globally.
However, higher cost of proton therapy is anticipated to hamper the market growth. In addition, proton therapy devices are very large in size and require large space with dedicated areas. The setup cost is exclusive of the device cost, which further increases investments, thereby restraining growth of this market. Moreover, introduction of proton therapy in emerging economies is expected to offer lucrative growth opportunities for key players in the market.
Companies Mentioned
Key Benefits
Key Market Segments
By Indication
By Product Type
By End User
By Region
For more information about this report visit https://www.researchandmarkets.com/r/ieiu8r
View source version on businesswire.com:https://www.businesswire.com/news/home/20221110005763/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD:
INDUSTRY KEYWORD: GENERAL HEALTH HEALTH ONCOLOGY
SOURCE: Research and Markets
Copyright Business Wire 2022.
PUB: 11/10/2022 09:57 AM/DISC: 11/10/2022 09:57 AM
http://www.businesswire.com/news/home/20221110005763/en